Monitoring for antidepressant-associated adverse events in the treatment of patients with major depressive disorder: An international consensus statement
Open accessThe DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Abstract
OBJECTIVES: These recommendations were designed to ensure safety for patients with major depressive disorder (MDD) and to aid monitoring and management of adverse effects during treatment with approved antidepressant medications. The recommendations aim to inform prescribers about both the risks associated with these treatments and approaches for mitigating such risks. METHODS: Expert contributors were sought internationally by contacting representatives of key stakeholder professional societies in the treatment of MDD (ASBDD, CANMAT, WFSBP and ISAD). The manuscript was drafted through iterative editing to ensure consensus. RESULTS: Adequate risk assessment prior to commencing pharmacotherapy, and safety monitoring during pharmacotherapy are essential to mitigate adverse events, optimise the benefits of treatment, and detect and assess adverse events when they occur. Risk factors for pharmacotherapy vary with individual patient characteristics and medication regimens. Risk factors for each patient need to be carefully assessed prior to initiating pharmacotherapy, and appropriate individualised treatment choices need to be selected. Some antidepressants are associated with specific safety concerns which were addressed. CONCLUSIONS: Risks of adverse outcomes with antidepressant treatment can be managed through appropriate assessment and monitoring to improve the risk benefit ratio and improve clinical outcomes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Boyer, E. W., & Shannon, M. (2005) · New England Journal of Medicine · doi:10.1056/nejmra041867 · Cited by 1,821
Snyder, H. R. (2013) · Psychological Bulletin · doi:10.1037/a0028727 · Cited by 1,667
Kennedy, S. H., Lam, R. W., McIntyre, R. S., Tourjman, S. V., Bhat, V., Blier, P., Hasnain, M., Jollant, F., Levitt, A. J., MacQueen, G. M., et al. (2016) · The Canadian Journal of Psychiatry · doi:10.1177/0706743716659417 · Cited by 1,181
Self-citationThe Arizona Sexual Experience Scale (ASEX): Reliability and Validity
A. McGahuey, A. J. G. (2000) · Journal of Sex & Marital Therapy · doi:10.1080/009262300278623 · Cited by 1,155
Suicidality in Pediatric Patients Treated With Antidepressant Drugs
Hammad, T. A., Laughren, T., & Racoosin, J. (2006) · Archives of General Psychiatry · doi:10.1001/archpsyc.63.3.332 · Cited by 1,054 · cited 1×
“Initiation of antidepressant treatment has been associated with possible increased risks of suicidal thinking and behaviour in young people aged 18–24 years during initial treatment (generally the first 1–2 months) (Hammad et al. 2006).”
BackgroundCleare, A., Pariante, C., Young, A., Anderson, I., Christmas, D., Cowen, P., Dickens, C., Ferrier, I., Geddes, J., Gilbody, S., et al. (2015) · Journal of Psychopharmacology · doi:10.1177/0269881115581093 · Cited by 759
Self-citationBauer, M., Pfennig, A., Severus, E., Whybrow, P. C., Angst, J., Möller, H.-J., & Šon behalf of the Task Force on Unipolar Depressive Disorders (2013) · The World Journal of Biological Psychiatry · doi:10.3109/15622975.2013.804195 · Cited by 632
Self-citationSafety and Efficacy of Sertraline for Depression in Patients With Heart Failure
O'Connor, C. M., Jiang, W., Kuchibhatla, M., Silva, S. G., Cuffe, M. S., Callwood, D. D., Zakhary, B., Stough, W. G., Arias, R. M., Rivelli, S. K., et al. (2010) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2010.03.068 · Cited by 535
Banerjee, S., Hellier, J., Dewey, M., Romeo, R., Ballard, C., Baldwin, R., Bentham, P., Fox, C., Holmes, C., Katona, C., et al. (2011) · The Lancet · doi:10.1016/s0140-6736(11)60830-1 · Cited by 532
Yonkers, K. A., Wisner, K. L., Stewart, D. E., Oberlander, T. F., Dell, D. L., Stotland, N., Ramin, S., Chaudron, L., & Lockwood, C. (2009) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2009.04.003 · Cited by 469
Lam, R. W., Kennedy, S. H., Grigoriadis, S., McIntyre, R. S., Milev, R., Ramasubbu, R., Parikh, S. V., Patten, S. B., & Ravindran, A. V. (2009) · Journal of Affective Disorders · doi:10.1016/j.jad.2009.06.041 · Cited by 431
Self-citationSide effects of antidepressants during long-term use in a naturalistic setting
Bet, P. M., Hugtenburg, J. G., Penninx, B. W. J. H., & Hoogendijk, W. J. G. (2013) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2013.05.001 · Cited by 239 · cited 2×
“2015), mirtazapine (Bet et al. 2013) and tricyclic antidepressants (Berken et al.”
BackgroundThe Elephant on the Couch: Side-Effects of Psychotherapy
Berk, M., & Parker, G. (2009) · Australian & New Zealand Journal of Psychiatry · doi:10.1080/00048670903107559 · Cited by 216
Self-citationOverweight and Obesity Affect Treatment Response in Major Depression
Kloiber, S., Ising, M., Reppermund, S., Horstmann, S., Dose, T., Majer, M., Zihl, J., Pfister, H., Unschuld, P. G., Holsboer, F., et al. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.10.001 · Cited by 208 · cited 1×
“There is also evidence that obesity is associated with decreased response to antidepressants (Kloiber et al. 2007; Woo et al. 2016).”
BackgroundRamasubbu, R., Taylor, V. H., Samaan, Z., Sockalingham, S., Li, M., Patten, S., Rodin, G., Schaffer, A., Beaulieu, S., & McIntyre, R. S. (2012) · Annals of Clinical Psychiatry · doi:10.1177/104012371202400110 · Cited by 206
Self-citationBauer, M., Severus, E., Köhler, S., Whybrow, P. C., Angst, J., Möller, H.-J., & on behalf of the Wfsbp Task Force on Treatment Guidelines for Unipolar Depressive Disorders (2015) · The World Journal of Biological Psychiatry · doi:10.3109/15622975.2014.1001786 · Cited by 199
Self-citationAntidepressants' Black-Box Warning — 10 Years Later
Friedman, R. A. (2014) · New England Journal of Medicine · doi:10.1056/nejmp1408480 · Cited by 171
An Electronic Health Records Study of Long-Term Weight Gain Following Antidepressant Use
Blumenthal, S. R., Castro, V. M., Clements, C. C., Rosenfield, H. R., Murphy, S. N., Fava, M., Weilburg, J. B., Erb, J. L., Churchill, S. E., Kohane, I. S., et al. (2014) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2014.414 · Cited by 151 · cited 2×
“2006) or no difference (Blumenthal et al. 2014) when compared to other antidepressants.”
ResultAnderson, H. D., Pace, W. D., Libby, A. M., West, D. R., & Valuck, R. J. (2012) · Clinical Therapeutics · doi:10.1016/j.clinthera.2011.11.024 · Cited by 147
Ratheesh, A., Davey, C., Hetrick, S., Alvarez‐Jimenez, M., Voutier, C., Bechdolf, A., McGorry, P. D., Scott, J., Berk, M., & Cotton, S. M. (2017) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.12686 · Cited by 142 · cited 1×
“including the boundaries between mixed states and agitated depression, and readers are referred to recent reviews for a detailed exposition of the subject of mixed states and transition to bipolar disorder (Swann et al. 2013; Ratheesh et al. 2017).”
BackgroundSelf-citationHodge, J. M., Wang, Y., Berk, M., Collier, F. M., Fernandes, T. J., Constable, M. J., Pasco, J. A., Dodd, S., Nicholson, G. C., Kennedy, R. L., et al. (2013) · Biological Psychiatry · doi:10.1016/j.biopsych.2012.11.003 · Cited by 122 · cited 1×
“This has been linked to evidence that serotonergic agents influence osteoblast and osteoclast development and bone formation (Williams et al. 2008; Hodge et al. 2013), although the clinical significance of these findings is still under investigation.”
BackgroundSelf-citationMadhusoodanan, S., Alexeenko, L., Sanders, R., & Brenner, R. (2010) · Annals of Clinical Psychiatry · doi:10.1177/104012371002200303 · Cited by 121
Williams, L. J., Henry, M. J., Berk, M., Dodd, S., Jacka, F. N., Kotowicz, M. A., Nicholson, G. C., & Pasco, J. A. (2008) · International Clinical Psychopharmacology · doi:10.1097/yic.0b013e3282f2b3bb · Cited by 117
Self-citationCognitive Effects of Pharmacotherapy for Major Depressive Disorder: A Systematic Review
Keefe, R. S. E., McClintock, S. M., Roth, R. M., Doraiswamy, P. M., Tiger, S., & Madhoo, M. (2014) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.13r08609 · Cited by 107
Carta, M. G., Hardoy, M., Garofalo, A., Pisano, E., Nonnoi, V., Intilla, G., Serra, G., Balestrieri, C., Chessa, L., Cauli, C., et al. (2007) · Clinical Practice and Epidemiology in Mental Health · doi:10.1186/1745-0179-3-22 · Cited by 91
Spindelegger, C. J., Papageorgiou, K., Grohmann, R., Engel, R., Greil, W., Konstantinidis, A., Agelink, M. W., Bleich, S., Ruether, E., Toto, S., et al. (2015) · International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyu080 · Cited by 82
Self-citationWoo, Y., Seo, H.-J., McIntyre, R., & Bahk, W.-M. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17010080 · Cited by 79 · cited 1×
“There is also evidence that obesity is associated with decreased response to antidepressants (Kloiber et al. 2007; Woo et al. 2016).”
BackgroundSelf-citationAntidepressant-induced hepatotoxicity
Lucena, M. I., Carvajal, A., Andrade, R. J., & Velasco, A. (2003) · Expert Opinion on Drug Safety · doi:10.1517/14740338.2.3.249 · Cited by 78 · cited 1×
“Drug-induced liver injury is most likely to occur in the first 6 months from initiating antidepressant therapy, although the latency can vary with agent (Lucena et al. 2003).”
BackgroundMcIntyre, R. S., Suppes, T., Tandon, R., & Ostacher, M. (2017) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.16cs10885 · Cited by 61
Self-citationGinsberg, L. D. (2009) · CNS Spectrums · doi:10.1017/s1092852900026353 · Cited by 19
Cited by
Major Depressive Disorder: Advances in Neuroscience Research and Translational Applications
Li, Z., Ruan, M., Chen, J., & Fang, Y. (2021) · Neuroscience Bulletin · doi:10.1007/s12264-021-00638-3 · Cited by 326
Li, X., Qin, X.-M., Tian, J.-S., Gao, X.-X., Du, G.-H., & Zhou, Y.-Z. (2021) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2020.113281 · Cited by 92
Pharmacological Augmentation in Unipolar Depression: A Guide to the Guidelines
Taylor, R. W., Marwood, L., Oprea, E., DeAngel, V., Mather, S., Valentini, B., Zahn, R., Young, A. H., & Cleare, A. J. (2020) · International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyaa033 · Cited by 76
“A recent consensus statement pertaining to antidepressant adverse events confirmed the need for adequate risk assessment and safety monitoring when initiating pharmacological treatment for depression (Dodd et al., 2018), and so this should be an essential part of any treatment guideline, particularly where polypharmac…”
BackgroundSelf-citationFramer, A. (2021) · Therapeutic Advances in Psychopharmacology · doi:10.1177/2045125321991274 · Cited by 73
Metadata
- Authors
- Dodd, S., Mitchell, P. B., Bauer, M., Yatham, L., Young, A. H., Kennedy, S. H., Williams, L., Suppes, T., Lopez Jaramillo, C., Trivedi, M. H., Fava, M., Rush, A. J., McIntyre, R. S., Thase, M. E., Lam, R. W., Severus, E., Kasper, S., & Berk, M.
- Venue
- The World Journal of Biological Psychiatry
- Publisher
- Informa UK Limited
- Published
- 2017-10-06
- Volume
- 19
- Issue
- 5
- Pages
- 330-348
- ISSN
- 1562-2975 (ISSN-L)
- 1814-1412
- OpenAlex
- W2763492979
- Cited by
- 68
- References
- 30
- FWCI
- 2.45
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.